Study on the risk factors for persistent infection of high-risk human papillomavirus after cervical conization

Study on the risk factors for persistent infection of high-risk human papillomavirus after cervical conization

Objective To analyze the risk factors of persistent infection of high-risk human papillomavirus (HR-HPV) after cervical conization, so as to identify the high-risk population of residual and recurrent cervical lesions after cervical conization. Method A total of 467 patients with one more HR-HPV inf...

Full description

Saved in:

Bibliographic Details
Main Author:	FU Xina, XU Xin, LI Tianjie, JIN Ying
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2024-08-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|high-risk human papillomavirus\|cervical lesions\|cervical cancer\|cervical conization
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1732171265015-634037049.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic Prediction for Recurrent/Residual CIN in HSIL Patients After Conization: An Updated Retrospective Study Based on Ambulatory Surgery
by: Huang G, et al.
Published: (2024-11-01)

Type-Specific Persistence/Clearance Results in Human Papillomavirus Infections in Turkish Women
by: Haci Ozturk Sahin, et al.
Published: (2021-12-01)

Cervical Cancer Visual Screening Experience in the Republic of Tajikistan
by: Nilufar Muhsinzoda, et al.
Published: (2024-04-01)

Outcomes and associated factors of cervical human papillomavirus infection among 608 women in Shenzhen, China, 2018–2023
by: Zhenghan Lv, et al.
Published: (2025-01-01)

The Relationship Between Cervicovaginal Infection, Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia in Romanian Women
by: Anca Daniela Brăila, et al.
Published: (2025-01-01)

Human papillomavirus (HPV) genotypes and risk determinants among Nigerian women with cervical lesions
by: Abigail Zakka, et al.
Published: (2024-05-01)

Prevalence and Genotyping of Human Papillomavirus Infections in Females and Males in Zhejiang, China
by: Wang Y, et al.
Published: (2024-11-01)

Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
by: Sha Ji, et al.
Published: (2025-01-01)

Analysis of HPV genotype differences in different stages of cervical intraepithelial neoplasia
by: YU Jingmin, et al.
Published: (2024-11-01)

High frequency of HPV high-risk preventable genotypes in Ecuadorian women with invasive cervical cancer
by: Gustavo David García Muentes, et al.
Published: (2024-12-01)

Cervical intraepithelial neoplasia and cervical cancer in Hunan Province, China, 2020-2023
by: Xu Zhou, et al.
Published: (2024-12-01)

Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines
by: Qian Zheng, et al.
Published: (2025-01-01)

Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study
by: Xun Tian, et al.
Published: (2024-12-01)

Human Leucocyte Antigen Class II Risk and Protective Alleles in Women with Cervical Intraepithelial Neoplasia
by: Olga Plisko, et al.
Published: (2024-03-01)

Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population
by: Hong Tao, et al.
Published: (2024-11-01)

Vaginal microbiome distinction in women with HPV+, cervical intraepithelial neoplasia, and cervical cancer, a retrospective study
by: Yuanyue Li, et al.
Published: (2025-01-01)

Study on the clinical characteristics, persistent infection capability and viral load of human papillomavirus type 26 single infection
by: Zuyi Chen, et al.
Published: (2024-11-01)

Evaluation of cervical cytological abnormalities in correlation with clinical findings in Iraqi patients
by: Zainab Abbas Hassooni, et al.
Published: (2024-01-01)

HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China
by: Yuling Kou, et al.
Published: (2024-12-01)

Investigating the impact of persistent HPV infection on recurrence of lesions post-surgery for early-stage cervical cancer and related influencing factors
by: Jing Na, et al.
Published: (2025-02-01)

Pioneering molecular screening for cervical precursor lesions and cervical cancer in sera
by: Paulina Miranda-Falconi, et al.
Published: (2024-11-01)

Hpv-Specific Risk Management in Cervical Pathology Screening and Comparison of Pathological Results
by: Ali Acar, et al.
Published: (2023-12-01)

The Diagnostic Significance of Combined Screening and Human Papillomavirus 16 and 18 Cycle Threshold Values for CIN2+ Cervical Lesions
by: Bai X, et al.
Published: (2024-11-01)

Application of 2D polymerase chain reaction for single-tube detection of high-risk human papillomaviruses
by: Weifeng Wang, et al.
Published: (2025-01-01)

Exploring the Clinical Signatures of Cervical Dysplasia Patients and Their Association With Vaginal Microbiota
by: Liqin Cheng, et al.
Published: (2024-12-01)

Predictors of Human Papillomavirus (HPV) Vaccine Acceptability Among Physicians, Their Knowledge on Cervical Cancer, and Factors Influencing Their Decision to Recommend It
by: Alosaimi B, et al.
Published: (2024-11-01)

Study of the Prevalence of Human Papillomavirus Genotypes in Jeddah, Saudi Arabia
by: Mai M. El-Daly, et al.
Published: (2025-01-01)

Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis
by: Haiyue Wu, et al.
Published: (2025-02-01)

The value of endocervical curettage for diagnosis of cervical precancers or worse at colposcopy of women with atypical glandular cells cytology
by: Yusha Chen, et al.
Published: (2024-12-01)

Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status
by: Wenyu Lin, et al.
Published: (2025-01-01)

Cervical length of preoperative cervical cerclage prognostic impacted the effect of cervical insufficiency
by: Yayun Zhang, et al.
Published: (2025-01-01)

Clinical Performance and Safety of Cerviron® Vaginal Ovules in the Management of Symptomatic Cervical Lesions: A National, Multicentric Study
by: Izabella Petre, Ph.D, MD, et al.
Published: (2024-01-01)

Accuracy of POC testing systems for HPV screening: the importance of disease prevalence and characteristics of the screened population
by: Paolo Giorgi Rossi, et al.
Published: (2024-12-01)

Perceptions and Barriers to Human Papillomavirus Vaccination and Cervical Cancer Screenings: A Survey Study of Underserved Populations in North Texas
by: Sofia Eva Olsson, et al.
Published: (2024-12-01)

Cervical cerclage vs cervical pessary in women with cervical insufficiency: A multicentric, open-label, randomised, controlled pilot trial [the CEPEIC trial]
by: Andrea Gascón, et al.
Published: (2024-12-01)

The impact of an imperfect vaccine and pap cytologyscreening on the transmission of human papillomavirus and occurrenceof associated cervical dysplasia and cancer
by: Tufail Malik, et al.
Published: (2013-05-01)

Clinical factors of development of squamous intraepithelial cervical lesions of high grade in patients with papillomavirus infection
by: T. A. Dimitriadi, et al.
Published: (2020-06-01)

Evaluating human papillomavirus (HPV) self‐sampling among Latinas in the United States: A systematic review
by: Marisol S. Cora‐Cruz, et al.
Published: (2024-08-01)

The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review
by: Vijay Bhalerao, et al.
Published: (2024-11-01)

The Display between HPV Infection and Host Immunity in Cervical Cancer
by: Yuanyuan Gu, et al.
Published: (2024-12-01)